STOCK TITAN

Grail Inc reported $147.2M in revenue and a $408.4M net loss for fiscal 2025. See the full GRAL financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GRAIL granted 55,867 inducement RSUs to 59 new non-executive employees, vesting over about four years starting August 31, 2027.

(Moderate)
(Very Positive)
Tags

GRAIL (GRAL) granted employment inducement restricted stock units to new non-executive employees under Nasdaq Listing Rule 5635(c)(4), as of September 3, 2026.

The awards cover an aggregate of 55,867 RSUs tied to GRAIL common stock, issued to 59 recently hired non-executive employees as a material inducement to join the company. The RSUs were granted under GRAIL's Inducement Equity Incentive Plan and its standard restricted stock award agreement. The plan is used only for individuals who were not previously employed by GRAIL, or who return after a bona fide break in service. The RSUs vest over approximately four years, with 25% vesting on August 31, 2027 and the remaining portions vesting on each one-year anniversary thereafter, subject to continued employment with GRAIL or its affiliates.

Loading...
Loading translation...

Positive

  • 55,867 inducement RSUs help attract and retain 59 new non-executive hires
  • Four-year vesting schedule with 25% cliff vesting in 2027 supports employee retention

Negative

  • Equity inducement awards covering 55,867 shares create incremental share-based dilution over the vesting period

Market Context

Recent insider records showed 12,900 shares sold and none bought, adding governance context to the e...
Analysis

Recent insider records showed 12,900 shares sold and none bought, adding governance context to the employee-grant announcement. Investors can weigh that record alongside vesting terms and continued-employment conditions.

Key Figures

Shares underlying RSUs: 55,867 shares Recipients: 59 employees Vesting period: four years +2 more
5 metrics
Shares underlying RSUs 55,867 shares Employee inducement grants
Recipients 59 employees Recently hired non-executive employees
Vesting period four years RSU vesting schedule
Initial vesting percentage 25% Vests Aug. 31, 2027
Vesting date Aug. 31, 2027 First scheduled RSU vesting date

Historical Context

5 past events · Latest: Aug 31 (Neutral)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Aug 31 Healthcare conference presentation Neutral +0.6% Management presentation scheduled for Morgan Stanley's healthcare conference
Aug 07 FDA advisory meeting Neutral +9.6% FDA advisory committee scheduled to review Galleri's PMA application
Aug 05 Second-quarter earnings Neutral -14.5% Revenue growth and ongoing losses were reported for the second quarter
Jul 30 Growth conference presentation Neutral -3.6% Management presentation scheduled for Canaccord Genuity's growth conference
Jul 29 Earnings release scheduling Neutral +12.1% Second-quarter financial results release and webcast were scheduled

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior news reactions were mixed across conference, regulatory-scheduling, and earnings-related announcements, with no consistent directional response.

Key Terms

restricted stock units, nasdaq listing rule 5635(c)(4)
2 terms
restricted stock units financial
"granted equity awards in the form of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
nasdaq listing rule 5635(c)(4) regulatory
"in accordance with Nasdaq Listing Rule 5635(c)(4)"
NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SUNNYVALE, Calif., Sept. 3, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of 55,867 shares of GRAIL's common stock to 59 recently hired non-executive employees as an inducement material to their acceptance of employment with GRAIL. The employment inducement awards were granted under GRAIL's Inducement Equity Incentive Plan and related form of restricted stock award agreement in accordance with Nasdaq Listing Rule 5635(c)(4).

GRAIL, Inc. is a healthcare company whose mission is to detect cancer early when it can be cured.

The inducement plan is used exclusively for the grant of equity awards to individuals who were not previously employees of GRAIL, or following a bona fide period of non-employment, as an inducement material to such individuals entering into employment with GRAIL, pursuant to Nasdaq Listing Rule 5635(c)(4).

The RSUs vest over an approximately four year period, with 25% of the award vesting Aug. 31, 2027, and on each one year anniversary of those respective dates thereafter, subject to continued employment with GRAIL (or any successor to or subsidiary of the Company) through the vesting dates.

About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Sunnyvale, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.

For more information, visit grail.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302869327.html

SOURCE GRAIL, Inc.

FAQ

What equity awards did GRAIL (GRAL) announce on September 3, 2026?

GRAIL announced grants of restricted stock units (RSUs) covering an aggregate of 55,867 shares of its common stock to 59 recently hired non-executive employees as inducement awards tied to their acceptance of employment.

How many employees are receiving inducement RSUs from GRAIL (GRAL) and in what amount?

A total of 59 recently hired non-executive employees are receiving inducement awards consisting of RSUs underlying an aggregate of 55,867 shares of GRAIL common stock, granted as a condition material to their acceptance of employment.

Under which plan and Nasdaq rule were the new GRAIL (GRAL) RSUs granted?

The inducement RSUs were granted under GRAIL's Inducement Equity Incentive Plan and related restricted stock award agreement, in accordance with Nasdaq Listing Rule 5635(c)(4), which permits equity grants as a material inducement to employment.

What is the vesting schedule for the new GRAIL (GRAL) inducement RSUs?

The RSUs vest over approximately four years. 25% of each award vests on August 31, 2027, and the remaining 75% vests in equal portions on each one-year anniversary of that date, subject to the employee’s continued employment with GRAIL or its affiliates.

Who is eligible for grants under GRAIL's Inducement Equity Incentive Plan (GRAL)?

The inducement plan is used exclusively for individuals who were not previously employees of GRAIL, or who return after a bona fide period of non-employment, and is intended as a material inducement for these individuals to enter into employment with GRAIL.

Why did GRAIL (GRAL) issue these inducement RSUs?

GRAIL issued these RSUs as inducement awards that are material to the recipients’ acceptance of employment. The company uses its Inducement Equity Incentive Plan specifically to grant equity awards intended to help attract new employees under Nasdaq Listing Rule 5635(c)(4).